The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Biodefense

Senate Stimulus: Good and Bad Outcomes for Funding Biotech

The latest Senate deal provides an extra $6.5 billion to NIH, amounting to $10 billion for biomedical research but also to improve research infrastructure in NIH facilities. According to Senator Arlen Specter, Ranking Republican on the Senate Health and Human Services Appropriations Subcommittee, the monies would be divvied up among NIH agencies in amounts proportional to their fiscal year 2008 funding. He said that economists estimate that the additional funds could lead to 70,000 new jobs in the health industry over two years.

The latest Senate stimulus deal cuts $870 million for pandemic influenza preparedness efforts. This funding was largely set aside for advanced development of novel vaccines, therapeutics and diagnostics. This is quite different from the earlier stage work that would be funded through NIH. I have heard that the funding would not only fund development efforts for flu, but also allow Health and Human Services to support other advanced development programs, namely for biodefense.

Bookmark and Share

Dare We Compare?

Follow

Get every new post delivered to your Inbox.

Join 130 other followers